These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Use of aminoglycosides in elderly patients. Pharmacokinetic and clinical considerations. Mörike K; Schwab M; Klotz U Drugs Aging; 1997 Apr; 10(4):259-77. PubMed ID: 9108987 [TBL] [Abstract][Full Text] [Related]
24. [Changes in pharmacokinetics in elderly patients]. Nadai M; Katoh M Nihon Rinsho; 2013 Jun; 71(6):999-1003. PubMed ID: 23855202 [TBL] [Abstract][Full Text] [Related]
25. [Geriatric pharmacology. Pharmacokinetics and pharmacodynamics in the elderly. Problems with geriatric and nootropic drugs]. Turnheim K Wien Klin Wochenschr; 1995; 107(12):349-56. PubMed ID: 7631505 [TBL] [Abstract][Full Text] [Related]
26. Quinolone disposition in the elderly. Practical implications. Nilsson-Ehle I; Ljungberg B Drugs Aging; 1991; 1(4):279-88. PubMed ID: 1794020 [TBL] [Abstract][Full Text] [Related]
27. Comparative pharmacokinetic changes and drug therapy in an older population. Lamy PP J Am Geriatr Soc; 1982 Nov; 30(11 Suppl):S11-9. PubMed ID: 6752251 [TBL] [Abstract][Full Text] [Related]
28. Choice and use of newer anticonvulsant drugs in older patients. Willmore LJ Drugs Aging; 2000 Dec; 17(6):441-52. PubMed ID: 11200305 [TBL] [Abstract][Full Text] [Related]
30. Pharmacologic basis for developing rational drug regimens for elderly patients. Goldberg PB; Roberts J Med Clin North Am; 1983 Mar; 67(2):315-31. PubMed ID: 6338318 [TBL] [Abstract][Full Text] [Related]
31. Drug therapy in the elderly. Williams L; Lowenthal DT South Med J; 1992 Feb; 85(2):127-31. PubMed ID: 1738877 [TBL] [Abstract][Full Text] [Related]
32. Age-dependent changes of the kidneys: pharmacological implications. Mühlberg W; Platt D Gerontology; 1999; 45(5):243-53. PubMed ID: 10460985 [TBL] [Abstract][Full Text] [Related]
33. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy. Perucca E; Cloyd J; Critchley D; Fuseau E Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564 [TBL] [Abstract][Full Text] [Related]
35. The influence of old age and enzyme inducing comedication on the pharmacokinetics of valproic acid at steady-state: A case-matched evaluation based on therapeutic drug monitoring data. Fattore C; Messina S; Battino D; Croci D; Mamoli D; Perucca E Epilepsy Res; 2006 Aug; 70(2-3):153-60. PubMed ID: 16730950 [TBL] [Abstract][Full Text] [Related]
36. A systematic comparison of cockcroft-gault and modification of diet in renal disease equations for classification of kidney dysfunction and dosage adjustment. Park EJ; Wu K; Mi Z; Dong T; Lawrence JP; Ko CW; Huang SM; Zhang L; Crentsil V; Zhang J; Xu NN Ann Pharmacother; 2012 Sep; 46(9):1174-87. PubMed ID: 22932303 [TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic and pharmacodynamic factors that can affect sensitivity to neurotoxic sequelae in elderly individuals. Ginsberg G; Hattis D; Russ A; Sonawane B Environ Health Perspect; 2005 Sep; 113(9):1243-9. PubMed ID: 16140636 [TBL] [Abstract][Full Text] [Related]
38. Medication in the elderly. George CF Ann Acad Med Singap; 1987 Apr; 16(2):277-80. PubMed ID: 3318657 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetic and pharmacodynamic aspects of oral moxifloxacin 400 mg/day in elderly patients with acute exacerbation of chronic bronchitis. Pea F; Pavan F; Lugatti E; Dolcet F; Talmassons G; Screm MC; Furlanut M Clin Pharmacokinet; 2006; 45(3):287-95. PubMed ID: 16509760 [TBL] [Abstract][Full Text] [Related]
40. Influence of aging on serum phenytoin concentrations: a pharmacokinetic analysis based on therapeutic drug monitoring data. Battino D; Croci D; Mamoli D; Messina S; Perucca E Epilepsy Res; 2004; 59(2-3):155-65. PubMed ID: 15246117 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]